| Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1 D García-Yoldi, CM Marín, MJ de Miguel, PM Muñoz, JL Vizmanos, ... Clinical chemistry 52 (4), 779-781, 2006 | 281 | 2006 |
| Novel translocations that disrupt the platelet‐derived growth factor receptor β (PDGFRB) gene in BCR–ABL‐negative chronic myeloproliferative disorders EJ Baxter, S Kulkarni, JL Vizmanos, R Jaju, G Martinelli, N Testoni, ... British journal of haematology 120 (2), 251-256, 2003 | 108 | 2003 |
| Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions M Shugay, I Ortiz de Mendíbil, JL Vizmanos, FJ Novo Bioinformatics 29 (20), 2539-2546, 2013 | 107 | 2013 |
| A simple and a reliable method to quantify antioxidant activity in vivo MP de Torre, RY Cavero, MI Calvo, JL Vizmanos Antioxidants 8 (5), 142, 2019 | 97 | 2019 |
| TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia X Agirre, FJ Novo, MJ Calasanz, MJ Larráyoz, I Lahortiga, M Valgañón, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 2003 | 96 | 2003 |
| Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients X Agirre, JL Vizmanos, MJ Calasanz, M García-Delgado, MJ Larráyoz, ... Oncogene 22 (7), 1070-1072, 2003 | 96 | 2003 |
| TICdb: a collection of gene-mapped translocation breakpoints in cancer FJ Novo, IO de Mendíbil, JL Vizmanos BMC genomics 8, 1-5, 2007 | 90 | 2007 |
| Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies MD Odero, FH Grand, S Iqbal, F Ross, JP Roman, JL Vizmanos, ... Leukemia 19 (2), 245-252, 2005 | 87 | 2005 |
| NIN , a Gene Encoding a CEP110-Like Centrosomal Protein, Is Fused to PDGFRB in a Patient with a t(5;14)(q33;q24) and an Imatinib-Responsive … JL Vizmanos, FJ Novo, JP Román, EJ Baxter, I Lahortiga, MJ Larráyoz, ... Cancer research 64 (8), 2673-2676, 2004 | 78 | 2004 |
| Phenolic compounds inhibit 3T3-L1 adipogenesis depending on the stage of differentiation and their binding affinity to PPARγ P Aranaz, D Navarro-Herrera, M Zabala, I Miguéliz, A Romo-Hualde, ... Molecules 24 (6), 1045, 2019 | 71 | 2019 |
| Clinical variability of patients with the t (6; 8)(q27; p12) and FGFR1OP-FGFR1 fusion: two further cases. JL Vizmanos, R Hernández, MJ Vidal, MJ Larráyoz, MD Odero, J Marín, ... The Hematology Journal: the Official Journal of the European Haematology …, 2004 | 66 | 2004 |
| Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements I Lahortiga, I Vázquez, X Agirre, MJ Larrayoz, JL Vizmanos, A Gozzetti, ... Genes, Chromosomes and Cancer 40 (3), 179-189, 2004 | 62 | 2004 |
| JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report on a series of 349 patients JL Vizmanos, C Ormazábal, MJ Larrayoz, NCP Cross, MJ Calasanz Leukemia 20 (3), 534-535, 2006 | 61 | 2006 |
| NUP98 Is Fused to Adducin 3 in a Patient with T-Cell Acute Lymphoblastic Leukemia and Myeloid Markers, with a New Translocation t(10;11)(q25 … I Lahortiga, JL Vizmanos, X Agirre, I Vázquez, JC Cigudosa, MJ Larrayoz, ... Cancer Research 63 (12), 3079-3083, 2003 | 47 | 2003 |
| Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse … P Bolufer, FL Coco, D Grimwade, E Barragán, D Diverio, B Cassinat, ... Haematologica 86 (6), 570-576, 2001 | 42 | 2001 |
| t(10;16)(q22;p13) and MORF‐CREBBP fusion is a recurrent event in acute myeloid leukemia JL Vizmanos, MJ Larráyoz, I Lahortiga, F Floristán, C Alvarez, MD Odero, ... Genes, Chromosomes and Cancer 36 (4), 402-405, 2003 | 40 | 2003 |
| Genomic hallmarks of genes involved in chromosomal translocations in hematological cancer M Shugay, I Ortiz de Mendibil, JL Vizmanos, FJ Novo PLoS computational biology 8 (12), e1002797, 2012 | 38 | 2012 |
| Effects of Sample Size and Full Sibs on Genetic Diversity Characterization: A Case Study of Three Syntopic Iberian Pond-Breeding Amphibians. MSÍ Sánchez-Montes G, Ariño AH, Vizmanos JL, Wang J Journal of Heredity 108 (5), 535-543, 2017 | 37 | 2017 |
| Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase Á Cuesta-Domínguez, M Ortega, C Ormazábal, M Santos-Roncero, ... PLoS One 7 (2), e32451, 2012 | 37 | 2012 |
| A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome MD Odero, JL Vizmanos, JP Román, I Lahortiga, C Panizo, MJ Calasanz, ... Genes, Chromosomes and Cancer 35 (1), 11-19, 2002 | 36 | 2002 |
Francisco Javier NovoDepartment of Biochemistry and Genetics. University of Navarra. SpainVerified email at unav.es
